ArticleCancer immunology, immunotherapy : CII2019
The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Maximilian Jenzer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it